- Home
- PMM vs SMTI Comparison
PMM vs SMTI Comparison
Compare PMM & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMM
- SMTI
- Stock Information
- Founded
- PMM 1989
- SMTI 1982
- Country
- PMM United States
- SMTI United States
- Employees
- PMM N/A
- SMTI N/A
- Industry
- PMM Investment Managers
- SMTI Medical/Dental Instruments
- Sector
- PMM Finance
- SMTI Health Care
- Exchange
- PMM Nasdaq
- SMTI Nasdaq
- Market Cap
- PMM 296.6M
- SMTI 288.2M
- IPO Year
- PMM N/A
- SMTI N/A
- Fundamental
- Price
- PMM $6.35
- SMTI $36.64
- Analyst Decision
- PMM
- SMTI Buy
- Analyst Count
- PMM 0
- SMTI 1
- Target Price
- PMM N/A
- SMTI $44.00
- AVG Volume (30 Days)
- PMM 118.3K
- SMTI 35.0K
- Earning Date
- PMM 01-01-0001
- SMTI 11-12-2024
- Dividend Yield
- PMM 4.68%
- SMTI N/A
- EPS Growth
- PMM N/A
- SMTI N/A
- EPS
- PMM 0.23
- SMTI N/A
- Revenue
- PMM N/A
- SMTI $78,056,873.00
- Revenue This Year
- PMM N/A
- SMTI $29.95
- Revenue Next Year
- PMM N/A
- SMTI $19.68
- P/E Ratio
- PMM $26.52
- SMTI N/A
- Revenue Growth
- PMM N/A
- SMTI 24.66
- 52 Week Low
- PMM $5.00
- SMTI $26.00
- 52 Week High
- PMM $6.42
- SMTI $43.25
- Technical
- Relative Strength Index (RSI)
- PMM 54.83
- SMTI 56.60
- Support Level
- PMM $6.34
- SMTI $34.50
- Resistance Level
- PMM $6.42
- SMTI $37.60
- Average True Range (ATR)
- PMM 0.07
- SMTI 1.88
- MACD
- PMM 0.02
- SMTI -0.23
- Stochastic Oscillator
- PMM 64.52
- SMTI 59.81
About PMM Putnam Managed Municipal Income Trust
Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.